Last reviewed · How we verify
Heavy Bupivacaine — Competitive Intelligence Brief
marketed
Local anesthetic (amide)
Voltage-gated sodium channels
Anesthesia
Small molecule
Live · refreshed every 30 min
Target snapshot
Heavy Bupivacaine (Heavy Bupivacaine) — Diskapi Yildirim Beyazit Education and Research Hospital. Heavy bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Heavy Bupivacaine TARGET | Heavy Bupivacaine | Diskapi Yildirim Beyazit Education and Research Hospital | marketed | Local anesthetic (amide) | Voltage-gated sodium channels | |
| ESL | ESL | Bial - Portela C S.A. | marketed | Voltage-gated sodium channel blocker; anticonvulsant | Voltage-gated sodium channels (Nav) | |
| Exparel + Bupivacaine | Exparel + Bupivacaine | Pacira Pharmaceuticals, Inc | marketed | Local anesthetic (liposomal formulation) | Voltage-gated sodium channels | |
| carbamazepine ER (Equetro) | carbamazepine ER (Equetro) | Massachusetts General Hospital | marketed | Anticonvulsant; mood stabilizer | Voltage-gated sodium channels | |
| Exparel TAP + multi-modal pain regimen | Exparel TAP + multi-modal pain regimen | Pacira Pharmaceuticals, Inc | marketed | Local anesthetic (liposomal formulation) | Voltage-gated sodium channels | |
| Suzetrigine (SUZ) | Suzetrigine (SUZ) | Vertex Pharmaceuticals Incorporated | marketed | Selective sodium channel inhibitor | Voltage-gated sodium channels (Nav) | |
| local infiltration of liposomal bupivacaine | local infiltration of liposomal bupivacaine | TriHealth Inc. | marketed | Local anesthetic (amide class) | Voltage-gated sodium channels |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Local anesthetic (amide) class)
- Poznan University of Medical Sciences · 4 drugs in this class
- Nantes University Hospital · 3 drugs in this class
- Bozyaka Training and Research Hospital · 2 drugs in this class
- ASST Gaetano Pini-CTO · 2 drugs in this class
- Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
- Chiang Mai University · 1 drug in this class
- Beijing Tiantan Hospital · 1 drug in this class
- Complejo Hospitalario Universitario de Granada · 1 drug in this class
- Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
- China Medical University, China · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Heavy Bupivacaine CI watch — RSS
- Heavy Bupivacaine CI watch — Atom
- Heavy Bupivacaine CI watch — JSON
- Heavy Bupivacaine alone — RSS
- Whole Local anesthetic (amide) class — RSS
Cite this brief
Drug Landscape (2026). Heavy Bupivacaine — Competitive Intelligence Brief. https://druglandscape.com/ci/heavy-bupivacaine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab